#immunotherapy
Immunotherapy Breakthrough Gives New Hope for Colorectal Cancer Patients
Colorectal cancer is currently the third most common cancer in the world, following lung and breast cancers. In recent years, doctors and researchers have noticed a steady increase in cases across many countries, including India. Despite the rising number of diagnoses, new medical advancements are offering hope to patients. One of the most promising developments is immunotherapy, a treatment that helps the body’s immune system detect and attack cancer cells more effectively. Unlik
Immunotherapy Breakthrough Gives New Hope for Colorectal Cancer Patients
Colorectal cancer is currently the third most common cancer in the world, following lung and breast cancers. In recent years, doctors and researchers have noticed a steady increase in cases across many countries, including India. Despite the rising number of diagnoses, new medical advancements are offering hope to patients. One of the most promising developments is immunotherapy, a treatment that helps the body’s immune system detect and attack cancer cells more effectively. Unlik
Russia’s Enteromix Cancer Vaccine Shows 100% Efficacy In Early Trials
Russia has taken a major step in the global fight against cancer with the announcement of Enteromix, a new mRNA-based cancer vaccine that has shown 100% efficacy and safety in early human trials. Developed by the National Medical Research Radiological Centre and the Engelhardt Institute of Molecular Biology, Enteromix was tested on 48 patients with colorectal cancer. The results revealed tumour shrinkage and zero serious side effects, positioning this innovatio
Russia’s Enteromix Cancer Vaccine Shows 100% Efficacy In Early Trials
Russia has taken a major step in the global fight against cancer with the announcement of Enteromix, a new mRNA-based cancer vaccine that has shown 100% efficacy and safety in early human trials. Developed by the National Medical Research Radiological Centre and the Engelhardt Institute of Molecular Biology, Enteromix was tested on 48 patients with colorectal cancer. The results revealed tumour shrinkage and zero serious side effects, positioning this innovatio









